By Emily Olsen | Published June 1, 2026
In a high-stakes legal confrontation that could reshape oversight of state-managed healthcare, the Commonwealth of Massachusetts has filed a sweeping lawsuit against UnitedHealthcare, the nation’s largest health insurer. The litigation, filed in Suffolk Superior Court, accuses the healthcare behemoth of systematically inflating the severity of illnesses among senior citizens enrolled in MassHealth managed care plans to extract at least $100 million in improper state payments.
The lawsuit alleges a sophisticated pattern of “upcoding”—a practice where insurers exaggerate the health needs of their members to secure higher reimbursement rates from government programs. As the largest provider of Senior Care Options (SCO) plans in Massachusetts, UnitedHealthcare now faces intense scrutiny over its fiscal integrity and its treatment of the state’s most vulnerable elderly population.
The Mechanics of the Alleged Scheme
MassHealth’s Senior Care Options program is designed to provide comprehensive, coordinated care to low-income adults over the age of 65. Because these individuals often have complex medical needs, the state utilizes a capitated payment model. In this system, insurers receive a set per-member, per-month fee based on the beneficiary’s clinical status.
The reimbursement structure is tiered into three levels:

- Level 1: Represents the healthiest tier with the lowest reimbursement rate.
- Level 2: Reserved for individuals with documented behavioral health conditions or substance use disorders.
- Level 3: The highest tier, intended for patients with the most severe health needs requiring intensive services.
According to the complaint, UnitedHealthcare manipulated these classifications to artificially inflate its revenue. The state contends that the insurer engaged in a multi-year effort to misrepresent the health status of its members, effectively “bumping” them into higher payment tiers despite a lack of medical necessity or supporting clinical evidence.
A Three-Pronged Strategy of Misrepresentation
The Massachusetts Attorney General’s office outlines three distinct methods by which UnitedHealthcare allegedly subverted the system:
1. Fabricated Behavioral Health Diagnoses
The state alleges that UnitedHealthcare classified numerous beneficiaries as “Level 2” patients—specifically citing conditions related to mental health or substance abuse—without any corresponding clinical documentation. In many instances, the patients had never received a diagnosis for these conditions, nor had they undergone any treatment or been prescribed medication for them. By assigning these labels, the insurer triggered higher monthly payments under false pretenses.
2. Failure to Disclose Known Improper Classifications
The lawsuit highlights a critical window beginning in 2018, when internal reviews reportedly alerted UnitedHealthcare that a significant portion of its beneficiary pool had been improperly categorized as “Level 3.” While the company did initiate a process to downgrade some of these members, the state alleges that UnitedHealthcare failed to disclose the prior overpayments to Massachusetts regulators. The insurer reportedly kept the funds and neglected to offer any restitution to the Medicaid program.
3. Exploitation of Skilled Nursing Assessments
Perhaps the most egregious allegation involves the submission of health assessments claiming that members required skilled nursing services. The state argues that these claims were frequently unfounded, as many beneficiaries neither needed nor received the intensive care that their “Level 3” status suggested. These assessments, often conducted in-home, served as the justification for the elevated billing rates that the state now characterizes as a fraudulent misuse of taxpayer dollars.

Chronology: From Internal Knowledge to Legal Action
- 2018: Internal company audits reportedly reveal that a substantial number of UnitedHealthcare members in Massachusetts are incorrectly classified at the highest reimbursement tier (Level 3).
- 2018–2025: During this seven-year period, UnitedHealthcare allegedly continues to collect inflated payments, even as it selectively downgrades certain patient files without notifying the state or returning the excess funds.
- January 2026: A U.S. Senate investigation concludes that UnitedHealth Group has been “aggressively” gaming the Medicare Advantage program, setting a national context for the company’s billing practices.
- Mid-2025: Reports confirm that the Department of Justice (DOJ) has launched an investigation into the company’s Medicare coding practices, heightening the regulatory pressure on the insurer.
- June 1, 2026: The Commonwealth of Massachusetts officially files suit in Suffolk Superior Court, seeking to claw back at least $100 million in allegedly ill-gotten gains.
Official Responses and the Stakes of Accountability
Attorney General Andrea Campbell has taken a firm stance, positioning the lawsuit as a necessary intervention to protect the state’s fiscal resources and the dignity of its seniors.
“The state’s managed care plans need to act in good faith on behalf of their members and the financial resources of our state’s Medicaid program,” Campbell said in a statement released on Friday. “This lawsuit sends a clear message that no company is above the law, and my office will hold companies accountable for exploiting vulnerable residents and misusing taxpayer dollars.”
UnitedHealth Group has yet to issue a comprehensive defense, though the company generally maintains that its coding practices are compliant with federal and state regulations. The insurer has historically argued that its home-visit assessment programs are designed to better identify and treat chronic conditions among the elderly, rather than to inflate billing.
Broader Implications: The Shadow of Medicare Advantage
This lawsuit does not exist in a vacuum. UnitedHealthcare’s business model has faced recurring accusations of upcoding for years, particularly within the Medicare Advantage (MA) market. The Massachusetts case mirrors concerns raised by federal lawmakers and regulators regarding the practice of sending nurses to perform home assessments specifically to uncover new diagnoses that justify higher payments—a practice critics often refer to as "chart scrubbing."
Regulatory Fallout
The convergence of a state-level lawsuit in Massachusetts and federal scrutiny from the DOJ suggests that the "wild west" era of managed care coding may be coming to an end. If Massachusetts succeeds, it could set a powerful legal precedent for other states to pursue their own Medicaid clawbacks. It may also force CMS (the Centers for Medicare & Medicaid Services) to tighten the rules governing in-home assessments, which have long been a flashpoint for abuse.

Impact on Managed Care Organizations (MCOs)
Managed care plans are a staple of modern Medicaid, but their profit-driven structure often creates a perverse incentive to maximize the “sickness” of their population. This litigation is likely to force MCOs across the country to audit their internal coding processes with newfound urgency. Should the courts find that UnitedHealthcare knowingly retained overpayments, the industry may face a wave of shareholder derivative suits and more rigorous, mandatory state audits.
Conclusion
The outcome of this case will be closely watched by healthcare policymakers and industry analysts alike. At its core, the dispute is about the tension between the financial interests of a multi-billion dollar corporation and the fundamental need to ensure that public health funds are used exclusively for the care of those who need it most.
As the legal proceedings in Suffolk Superior Court unfold, the citizens of Massachusetts will be waiting to see if the state can successfully recover the $100 million in taxpayer funds and whether this litigation will serve as the catalyst for meaningful reform in the oversight of managed care billing. For now, the reputation of one of the nation’s largest insurers hangs in the balance, as does the stability of the state’s commitment to its aging, low-income population.
